Post

Result in high-risk patients validates decades of research into mRNA-based therapeutic cancer vaccines. on.wsj.com/4zwRduC

on.wsj.comModerna, Merck Vaccine Succeeds in Preventing Melanoma From ReturningResult in high-risk patients validates decades of research into mRNA-based therapeutic cancer vaccines.

19/8/26, 10:49 am97 reposts290 likes

Sean Solo

@spqesq.bsky.social

19 Aug

Enraged Trump and RFK, Jr. said to be holding emergency meetings to sabotage the research, development, manufacture and distribution. #GOP-Death-Cult

Inverted Pyramid

@invertedpyramid.bsky.social

19 Aug

Unless my eyes deceived me, I believe mRNA was just validated several days ago.

Veratify

@veratify.bsky.social

19 Aug

V confirms this claim checks out. Multiple sources confirm the Phase 3 trial in high-risk melanoma patients validates the personalized mRNA cancer vaccine approach developed over decades. Real-time fact-checks on your feed: https://veratify.ai Errors or comments: info@veratify.ai